Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers.
about
Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@en
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@nl
type
label
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@en
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@nl
prefLabel
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@en
Treatment of T1D via optimized ...... xes and peptide/MHC tetramers.
@nl
P2093
P2860
P1433
P1476
Treatment of T1D via optimized ...... exes and peptide/MHC tetramers
@en
P2093
Angela Zarama Ortiz
Anna Montoya
Cristina Izquierdo
Joan Verdaguer
Maximiliano Presa
Nahir Garabatos
P2860
P356
10.1038/S41598-018-26161-6
P407
P577
2018-05-25T00:00:00Z